Trans-Lux Corporation (TNLX) 2.4000 $TNLX Trans-Lux

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trans-Lux Corporation (TNLX) 2.4000 $TNLX

Trans-Lux Reports Significantly Improved Results And Positive EBIDTA
PR Newswire - Wed Mar 30, 12:45PM CDT
Trans-Lux Corporation (OTC: TNLX) ("Trans-Lux" or the "Company", a leading supplier of Digital Displays and next generation LED lighting, yesterday reported significantly improved financial results for both the fourth quarter and the year ended December 31, 2015. Trans-Lux President and Chief Executive Officer J.M. Allain made the announcement while also stating that both the fourth quarter and the year had positive EBITDA.

Trans-Lux Corporation Reports Profitable Third Quarter, Increased Revenue And Strong EBITDA
PR Newswire - Fri Nov 13, 5:24PM CST
Trans-Lux Corporation (OTCQB: TNLX) ("Trans-Lux", a leading supplier of Digital Displays and next generation LED lighting, reported financial results for the quarter ended September 30, 2015. Trans-Lux President and Chief Executive Officer J.M. Allain made the announcement.

Trans-Lux Reports Improved Second Quarter Results
Marketwired - Thu Aug 13, 3:30PM CDT
Trans-Lux Corporation (OTCQB: TNLX) ("Trans-Lux", a leading supplier of Digital Displays and next generation LED lighting, reported financial results for the quarter ended June 30, 2015 on August 13, 2015. Trans-Lux President and Chief Executive Officer J.M. Allain made the announcement.

Media Alert: Trans-Lux Corp (TNLX) Has Not Been Sold
Marketwired - Thu Jun 18, 10:42AM CDT
Yesterday Trans-Lux (OTCQB: TNLX) made an announcement on the company's new design and production facility in Shenzhen, China and new technology partnerships with leading LED suppliers Prismaflex International (EURONEXT PARIS: ALPRI) in Haute-Rivoire, France, and Squadrat in Schwanstetten, Germany. This exciting news was erroneously reported in the Chinese media and other markets that Trans-Lux has been sold to Barco. This is completely inaccurate. Trans-Lux has not been sold -- and is not for sale.

Innovative Financing Program From TL Energy Delivers Profits to Users Who Deploy LED Lighting
Marketwired - Thu Nov 13, 9:52AM CST
TL Energy (TLE), a division of Trans-Lux Corporation (OTCQB: TNLX), a world leader in LED digital display and lighting technologies, announces the launch of a unique financing program initiated to further drive the use of LED tube lighting in commercial and industrial facilities. The financing program enables qualified businesses to profit from the use of TLE's industry proven LED lighting when converting from conventional fluorescent tube lamps. TLE partnered with Structured Finance Associates who secured an initial $25 million to launch the innovative financing program.

Trans-Lux Introduces Innovative TL Vision Court Side LED Displays
Marketwired - Tue Nov 04, 11:35AM CST
Trans-Lux Corporation (OTCQB: TNLX), a world leader in LED digital displays and LED lighting technologies, has released a new series of modular Court Side LED Displays under its premier TL Vision brand. The units provide a high-performance LED display in a sturdy steel frame optimized for reduced weight to allow the systems to be easily stored, moved and set up.

Trans-Lux Names Alex Gomez as Chief Revenue Officer
Marketwired - Tue Oct 28, 8:02AM CDT
Trans-Lux Corporation (OTCQB: TNLX), a world leader in LED digital displays and LED lighting technologies, announced today the appointment of Alex Gomez as Chief Revenue Officer (CRO). As CRO, Mr. Gomez will be responsible for growing overall company revenues and overseeing all sales and marketing across Trans-Lux's extensive product portfolios. He will also serve as relationship manager for the company's core clients.

Trans-Lux Posts Record $3 Million in TL Energy LED Lighting Sales Over Eight Week Run
Marketwired - Tue Oct 21, 8:01AM CDT
Trans-Lux Corporation (OTCQB: TNLX) continues to post record sales as the company's innovative TL Energy LED Lighting business model continues to gain traction. Launched in 2010, TL Energy offers turnkey solutions for commercial LED lighting that provide unique long-term financial and environmental benefits while providing significant savings that actually fund purchase and installation costs over time. By providing such a compelling value-add proposition, TL Energy continues to capture a large share of commercial LED lighting and display projects, and has just posted a record $3 million in LED lighting sales over an eight week run.

Trans-Lux Lights Up New Times Square Restaurant With Dynamic LED Displays
Marketwired - Tue Oct 14, 1:25PM CDT
Trans-Lux Corporation (OTCQB: TNLX) continues the company's pioneering role in developing the LED display landscape of New York's Times Square area and theater district. Most recently, Trans-Lux TL Vision LED displays were installed at URBO, the eclectic 26,000 square foot restaurant located at Eleven Times Square which opened in July 2014, and features five restaurants with 600 seats on three levels. The new TL Vision HD 8mm LED displays adorning the exterior of the restaurant are the first phase of a three-phase LED project for URBO employing Trans-Lux LED solutions.

Trans-Lux Names Alberto Shaio as Chief Operating Officer
Marketwire - Tue Oct 07, 1:14PM CDT
Trans-Lux Corporation (OTCQB: TNLX), a world leader in LED digital displays and LED lighting technologies, announced today the appointment of Alberto Shaio as Chief Operating Officer (COO), a new position within the company. As COO, Mr. Shaio will manage Trans-Lux's operations and organizational development, focusing on performance management to shape the company for continued success and strategic growth. Mr. Shaio currently sits on the Trans-Lux Corporation Board of Directors.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 213

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 25

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 48

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading